Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical implications of zolbetuximab-associated hypoalbuminemia in CLDN18.2-positive gastric or gastroesophageal junction cancer.
ESMO gastrointestinal oncology·2026
BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer.
ESMO gastrointestinal oncology·2026
Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practice.
ESMO gastrointestinal oncology·2026